Lindsey Langley, Executive Director for the American Cancer Society in the State of Tennessee, who highlights the organization’s efforts across the state, support services that continue through the COVID-19 pandemic, the focus on research that is taking place in Tennessee to develop new protocols and treatments to fight cancer, the need for financial support and an opportunity to participate in an exciting statewide virtual event on Thursday, November 12, 2020.
Cancer Screening During the COVID-19 Pandemic – At the onset of the COVID-19 pandemic, elective medical procedures, including cancer screening, were largely put on hold to prioritize urgent needs and reduce the risk of the spread of COVID-19 in healthcare settings. One consequence of this has been a substantial decline in cancer screening.
As states and other authorities re-open businesses and ease restrictions, many healthcare facilities are starting to offer elective procedures again, including cancer screening. Restarting cancer screening requires careful consideration of the risks and benefits of screening, along with ensuring safety for both patients and healthcare personnel.
Decisions about restarting screening depend on many factors, and they may not be the same for every person. They will likely vary by community while the pandemic continues.
Regular cancer screening is still important!
Cancer Research Funding Challenge – Due to the economic effects of COVID-19, your American Cancer Society is facing a significant funding shortage that is threatening our ability to invest in vital cancer research.
Save the date: Nov. 12, 2020 – American Cancer Society’s Virtual Gala – more information to follow soon!